Navigation Links
iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board
Date:3/15/2011

SAN DIEGO, March 15, 2011 /PRNewswire/ -- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that Stefan Zeuzem, M.D., has joined the company as Chair of the Scientific and Clinical Advisory Board.  Dr. Zeuzem will lead a respected group of hepatitis thought leaders in contributing their expertise to the clinical development of iTherX's lead compound, ITX-5061, a first-in-class hepatitis C entry inhibitor.

"Stefan Zeuzem brings more than 20 years of international clinical and research leadership in hepatitis viruses, as well as liver disease and transplantation to our team. iTherX is fortunate to have Dr. Zeuzem's invaluable guidance and perspective as we advance our lead compound ITX-5061, a hepatitis C viral entry inhibitor, through clinical development," said Flossie Wong-Staal, Ph.D., Chief Scientific Officer of iTherX.  "We have established a truly dynamic and experienced scientific and clinical advisory board to bring forward this novel class of compounds.  Along with our advisors, we believe ITX-5061 has the promise of preventing the entry of the hepatitis C virus into cells while complementing existing antiviral treatment."

Dr. Zeuzem currently serves as Chief of the Department of Medicine and Professor of Medicine at the Johann Wolfgang Goethe University Hospital in Frankfurt, Germany. His clinical areas of expertise include gastroenterology, hepatology, liver transplantation, endoscopy, gastrointestinal oncology, and endocrinology. Dr. Zeuzem's current research interests include cellular physiology, molecular biology of hepatitis viruses, viral kinetics, the role of hepatitis viruses in hepatocarcinogenesis, and the stratification and optimization of antiviral treatment. After receiving his medical training from the J.W. Goethe University Medical School, the University Of Cambridge School Of Clinical Medicine (United Kingdom), and the Univ
'/>"/>

SOURCE iTherX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
2. Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer
3. Qforma Appoints Two New Executives
4. Xeridiem Medical Devices Appoints Renae Moomjian, Vice President, Business Development
5. CareFusion Appoints Carlos M. Nunez, M.D. as Chief Medical Officer
6. Adeona Appoints George J. Brewer, M.D., Senior Vice President of Research & Development
7. WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors
8. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
9. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
10. West Appoints Two Directors and Announces Second Quarter 2011 Dividend
11. Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... AMSTERDAM , July 25, 2014 ... America is returning for the seventh year to São ... to 7 th August 2014. The event will co-locate ... America,s most comprehensive meeting point for the pharmaceutical ... the top 25 countries for pharmaceutical sales are now exploring ...
(Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... , Weltweite Exklusivlizenz ... ermöglicht QIAGEN die Entwicklung von Tests auf ... Blutkrebs  Neuer Test weist Mutationen ... Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten ...
Breaking Medicine Technology:CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 ... prices across the board for the Guinness International Champions ... and Olympiacos FC at Soldier Field on Sunday, ... offering their customer appreciation promo/coupon/offer code SOCCER-2014 for added ... amazing year for diehard soccer fans in North America. ...
(Date:7/25/2014)... (HealthDay News) -- Seniors are more easily distracted during ... study finds. "Almost any type of memory test ... of 25 on," study co-author Randi Martin, professor of ... release. However, Martin said, this study shows that ... older adults compared with younger adults. The study ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Sport ... for the recent Nike National Invitational Tournament (NIT) ... United States Junior National Tournament (USJN) in ... , The flooring for these prestigious national tournaments included ... 300,000 square feet of playing surface at McCormick Place ...
(Date:7/25/2014)... Reproductive Science Center (RSC) of New England ... Lead Physician at RSC Rhode Island, received the distinguished ... fertility care and community outreach issued by Providence Business ... Awards ceremony held July 24th at Salve Regina University ... regarded, emerging leaders in their field were recognized by ...
(Date:7/25/2014)... 25, 2014 Florida Hospital and MOSI officially ... organizations for years to come and make a difference in ... $2 million dollar check to provide the support needed to ... enable MOSI to transform the IMAX Dome Theatre from film ... the only IMAX Dome Theatre in the state of Florida, ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Distractions Seem More Troublesome With Age 2Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4
... may be associated with an increased ability to taste. For ... skip breakfast. The men had not eaten since 6:30 p.m. ... or bitter solutions and describe the flavor they tasted. The ... out after tasting them. One hour after lunch, the men ...
... with chemo-resistant leukemia, a new drug is showing promising ... experimenting with bacteria-based recombinant immunotoxins. An immunotoxin is bioengineered ... part of the antibodies that are commonly used to ... encouraging results in a phase II study. ,Researchers ...
... vaccine loses some of its effectiveness in the ... vaccinate their children against chickenpox between 12 months ... further investigate the vaccine after chickenpox outbreaks were ... nearly 350 children ages 13 months or older ...
... the third most common form of cancer in the United ... may provide protection against colon cancer. In addition, soy protein ... develop. ,Investigators fed five different diets to female mice ... designed to compare the effects of specific ingredients. Diet one ...
... up and get moving. Breast cancer survivors who ... esteem and better mood than sedentary breast cancer ... compared 40 women who said they regularly exercised ... survivors. Regular exercisers reported significantly more positive attitudes ...
... have an increased risk of heart disease and death. ... older women who participated in the Women's Health Initiative ... designed to determine how biological and lifestyle factors influence ... health conditions. For this study, participants were evaluated for ...
Cached Medicine News:
... holmium laser combines excellent cutting, ablation ... bloodless procedures. It is also extremely ... bladder stones of all compositions, making ... Because its laser light is transmitted ...
... new CO2 laser system with intensities up ... an exclusive design for easy handling and ... is the leader in a new generation ... of Dekas laser devices, like safety and ...
... The MedArt® 435 is a full system for ... which makes up a complete hair reduction system. ... ensure sufficient heating of the hair bulb and ... beam is distributed to the tissue through the ...
VERSASTEP™ Reposable Reusable Components (Standard Length)....
Medicine Products: